ESCAPE: An Open-Label Trial of Personalized Immunotherapy in Critically lll COVID-19 Patients

BACKGROUND: Macrophage activation-like syndrome (MALS) and complex immune dysregulation (CID) often underlie acute respiratory distress (ARDS) in COVID-19. We aimed to investigate the effect of personalized immunotherapy on clinical improvement of critical COVID-19. METHODS: In this open-label prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Karakike, Eleni, Dalekos, George N., Koutsodimitropoulos, Ioannis, Saridaki, Maria, Pourzitaki, Chryssa, Papathanakos, Georgios, Kotsaki, Antigone, Chalvatzis, Stamatios, Dimakopoulou, Vasiliki, Vechlidis, Nikolaos, Paramythiotou, Elisabeth, Avgoustou, Christina, Ioakeimidou, Aikaterini, Kouriannidi, Elli, Komnos, Apostolos, Neou, Evangelia, Rovina, Nikoletta, Stefanatou, Eleni, Milionis, Haralampos, Nikolaidis, George, Koutsoukou, Antonia, Damoraki, Georgia, Dimopoulos, George, Zoumpos, Vassileios, Eugen-Olsen, Jesper, Akinosoglou, Karolina, Gatselis, Nikolaos K., Koulouras, Vasilios, Gkeka, Eleni, Markou, Nikolaos, Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805059/
https://www.ncbi.nlm.nih.gov/pubmed/34852352
http://dx.doi.org/10.1159/000519090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805059/
https://www.ncbi.nlm.nih.gov/pubmed/34852352
http://dx.doi.org/10.1159/000519090

Ejemplares similares